Abstract
The reconstitution of a cell nucleus in a lipid bilayer‐enclosed synthetic cell makes great strides in bottom‐up synthetic biology. In this study, a method for assembling a nucleus in giant unilamellar vesicles (GUVs) is proposed. To induce reconstitution of the nucleus, the interphase egg extract of African clawed frogs Xenopus laevis is utilized, known as a biochemically controllable cell‐free system capable of transforming an added sperm chromatin into a nucleus in vitro. The GUV formation efficiency is enhanced by the inverted emulsion method through incorporating prolonged waiting time and adding chloroform into lipid‐dispersed oil, facilitating subsequent nuclear assembly reactions in the GUVs. Characterization of nucleus‐like structures formed in the GUVs revealed the presence of dense DNA and accumulated GFP‐NLS in the structure, indicative of functional nuclear import. Immunostaining further validated the presence of nuclear pore complexes on the surfaces of these nucleus‐like structures. The approach offers a versatile platform for constructing artificial cellular systems that closely mimic eukaryotic cells.
Keywords: bottom‐up synthetic biology, giant unilamellar vesicles, inverted emulsion, liposomes, nuclear assembly, synthetic cells, Xenopus egg extract
Cell nuclei have been reconstituted in membrane‐less compartments using Xenopus egg extract, but not within lipid bilayer‐enclosed compartments. This study modifies the inverted emulsion method by adding chloroform to the lipid‐dispersed oil and extending lipid monolayer formation at the oil–egg extract interface, enabling the encapsulation of egg extract into giant unilamellar vesicles (GUVs) and the assembly of nuclei within them.

1. Introduction
Cell nucleus serves as a crucial subcellular compartment in eukaryotic cells, responsible for overseeing the maintenance of genetic materials and orchestrating their functions. Recent advancements in bottom‐up synthetic biology have focused on constructing or integrating cell‐like functional subcellular compartments in synthetic cells.[ 1 , 2 , 3 , 4 , 5 ] These efforts aim to replicate the functions of natural subcellular compartments such as photosynthesis in chloroplasts,[ 6 , 7 , 8 ] mitochondrial respiration,[ 9 , 10 , 11 ] and spatial organization of gene expression reactions in the nucleus.[ 12 , 13 ] Among various eukaryotic subcellular compartments, the nucleus stands out as a central element in the regulation of eukaryotic cellular processes. Constructing the nucleus in synthetic cells encapsulated with a lipid bilayer represents a significant stride toward developing artificial eukaryotic cellular structures.[ 14 ] Reconstitution of natural cell nucleus has previously been achieved in bulk solution,[ 15 , 16 , 17 ] microfluidic devices,[ 18 , 19 ] and water‐in‐oil emulsions,[ 20 , 21 , 22 ] by utilizing egg extracts of the African clawed frog Xenopus laevis. The “interphase” egg extract of Xenopus laevis is known as a biochemically manipulable cell‐free system, capable of transforming sperm chromatin into a nucleus in vitro.[ 15 , 16 , 17 ] However, the challenge of assembling the nucleus in a lipid bilayer‐enclosed confinement remains unmet. While encapsulation of an unspecified type of the egg extract into lipid bilayer‐enclosed confinement has previously been reported,[ 23 ] the typical yield in encapsulation of the interphase egg extract is low. This low yield can be attributed to the reported destabilization of the lipid bilayer in the presence of Xenopus egg extract,[ 24 ] highlighting the challenge of achieving stability in the lipid membrane surrounding the egg extract. Thus, stabilizing the lipid bilayer could significantly improve the efficiency of encapsulation and enable the reconstitution of a nucleus in cell‐like confinement enclosed with a lipid membrane.
In this study, we reconstitute a cell nucleus in giant unilamellar vesicles (GUVs). To accomplish the assembly of a nucleus in GUVs, we confine interphase egg extract of Xenopus laevis supplemented with Xenopus sperm chromatin by the inverted emulsion method.[ 25 ] We incorporate an extended waiting time as a parameter to enhance GUV yield, based on the finding that the formation of a lipid monolayer at the oil‐water interface, a crucial step in the inverted emulsion method, often requires a prolonged period. Additionally, we introduce chloroform into our lipid‐dispersed oil, following reported procedures that involve adding organic solvents to promote GUV formation by aggregating lipids and improving their adsorption rate at the oil‐water interface.[ 26 ] Using GUVs formed by encapsulating the interphase egg extract, we induce nuclear assembly reactions in the GUVs. To confirm nuclear reconstitution, we first identify the functionality of the nuclear membrane by a nuclear import assay. Then, we conduct molecular confirmation of the nuclear membrane by immunostaining, and quantitatively characterize the nuclear assembly events and geometric features of the formed GUVs and nuclei.
2. Results
2.1. Formation of GUVs Encapsulating Xenopus Egg Extract
To improve the encapsulation of Xenopus interphase egg extract into GUVs by the inverted emulsion method, we assessed the impact of implemented waiting time (τ: duration of waiting time; τ = 0/60/120 min) and added chloroform (Δ: relative volume of added chloroform to the lipid‐dispersed oil; Δ = 0/5/10%) in our protocol of the inverted emulsion method (Figure 1 ; details on the preparation of Xenopus interphase egg extract, sperm chromatin, and intra‐GUV nuclear assembly are provided in “4. Experimental Section”). Representative confocal micrographs of the formed GUVs are shown in Figure 2A. At τ = 0 min and Δ = 0%, we observed that the number and size of GUVs encapsulating the egg extract were notably small, unlike the GUVs encapsulating a typical dilute aqueous solution shown in Figure S1 (Supporting Information). Meanwhile, we found an increasing trend in the number of GUVs encapsulating the egg extract with prolonged waiting time and higher volumes of added chloroform. These observations suggest that GUV‐formation via the inverted emulsion method can be enhanced by implementing prolonged waiting time and adding chloroform to lipid‐dispersed oil.
Figure 1.

Three‐step protocol for the assembly of a cell nucleus in GUVs. A) Preparation of Xenopus interphase egg extract. Sperm chromatin is added to the egg extract prior to encapsulation into GUVs. B) Encapsulation of sperm chromatin‐added interphase egg extract into GUVs by the inverted emulsion method. Lipid monolayers are formed at the interfaces between water and oil phases. The formation of a lipid monolayer at the interfaces is enhanced by incubating the interfaces for the duration of the waiting time (τ) and adding chloroform in a volume (Δ) into lipid‐dispersed oil. Centrifugal force (Fc) allows the egg extract emulsions surrounded by a lipid monolayer to pass through a lipid monolayer formed at the interface between the oil phase and the outside water phase, transforming them into GUVs. C) Induction of nuclear assembly reactions in GUVs by incubation at 22/23 °C for 90 min.
Figure 2.

Formation of GUVs encapsulating Xenopus interphase egg extract. A) Representative micrographs of GUVs encapsulating the sperm chromatin‐added interphase egg extract, formed using the inverted emulsion method. The symbol τ denotes the duration of waiting time, and Δ denotes the volume of chloroform added to the lipid‐dispersed oil. Magenta indicates lipid membrane (RhPE), and green indicates GFP dispersed in the egg extract. An inset shows a zoom‐in of a typical GUV formed at τ = 0 min and Δ = 0%. Scale bar: 10 µm. B) Number of GUVs plotted against τ (left) and Δ (right). C) Proportion of GUVs with mean GFP intensity exceeding the computed threshold among the observed GUVs. D) Diameter of all GUVs. E) Number of GUVs with diameter larger than 5 µm. F) Proportion of GUVs with diameter larger than 5 µm among the observed GUVs. Bars represent the mean (green) and Q1‐Q3 quartiles (magenta). See “4. Experimental Section” for the details on statistical analysis and Tables S1–S12 (Supporting Information) for the results.
To evaluate the impact of waiting time and chloroform addition, we analyzed four metrics: (i) the total number of GUVs, (ii) the proportion of egg extract‐encapsulating GUVs, (iii) the number of GUVs larger than 5 µm, and (iv) the fraction of GUVs larger than 5 µm relative to the total population. For (i), two‐way ANOVA (Table S1, Supporting Information) revealed significant effects of both waiting time (p ≈ 0.006) and chloroform volume (p < 0.001), with no significant interaction (p ≈ 0.08). However, post‐hoc tests (Tables S2,S3, Supporting Information) indicated that only chloroform significantly increased the number of GUVs, particularly between 0% versus 10% (p < 0.001) and 5% versus 10% (p ≈ 0.04), while waiting time did not result in significant post‐hoc differences, as shown in Figure 2B. For (ii), two‐way ANOVA (Table S4, Supporting Information) showed a highly significant effect of chloroform volume (p < 0.001), whereas neither waiting time (p ≈ 0.19) nor their interaction (p ≈ 0.24) was significant. Post‐hoc tests (Tables S5–S6, Supporting Information) further confirmed increased encapsulation efficiency with chloroform addition (0% versus 5% and 0% versus 10%; both p < 0.001), while waiting time had no significant effect, as shown in Figure 2C. For (iii), two‐way ANOVA (Table S7, Supporting Information) identified significant contributions from both waiting time (p ≈ 0.02) and chloroform volume (p < 0.001), with no significant interaction (p ≈ 0.10). Nevertheless, post‐hoc tests (Tables S8,S9, Supporting Information) confirmed that only chloroform addition significantly increased the number of larger GUVs (0% versus 10%, p ≈ 0.001; 5% versus 10%, p ≈ 0.007), while waiting time showed no significant pairwise differences (all p > 0.14), as shown in Figure 2E. Finally, for (iv), two‐way ANOVA (Table S10, Supporting Information) revealed a significant effect of waiting time (p ≈ 0.03), while neither chloroform volume (p ≈ 0.08) nor their interaction (p ≈ 0.79) had a significant impact. Post‐hoc comparisons (Tables S11,S12, Supporting Information) also showed a significant increase for waiting time (between 0 min and 120 min, p ≈ 0.02), while chloroform volume had no significant effect, as shown in Figure 2F. Overall, these results statistically indicate that chloroform addition enhances (1) GUV formation, (2) egg extract encapsulation efficiency, and (3) the number of larger GUVs, while waiting time increases (4) the fraction of larger GUVs within the total population.
2.2. Formation of Nucleus‐Like Structures in GUVs
To initiate nuclear assembly reactions in GUVs encapsulating sperm chromatin‐added Xenopus interphase egg extract, GUVs formed under various waiting time and chloroform conditions were incubated at 22 °C (or 23 °C) for 90 min. A nuclear import assay utilizing GFP fused with a nuclear localization signal derived from simian vacuolating virus 40 (GFP‐NLS; preparation details in “4. Experimental Section”) was conducted as the primary means of identifying nucleus assembly, following established protocols in water‐in‐oil emulsions.[ 20 , 21 , 22 ] In this assay, GFP‐NLS is expected to be transported into the nucleus if a functional nuclear membrane with nuclear pore complexes is assembled on the surface as illustrated in Figure 1C, while passive dispersion of GFP without the NLS‐peptide is anticipated in the GUV lumen. Hereafter, the former condition is denoted as “NLS(+)”, and the latter as “NLS(‐)”. Representative micrographs of these GUVs in the top row of Figures 3A and S2 (Supporting Information) demonstrated that GFP clearly accumulated at the same location as dense DNA in the GUVs under the NLS(+) condition, suggesting active nuclear import of GFP‐NLS into the assembled nucleus. In contrast, GFP was homogeneously dispersed in the GUVs containing dense DNA under the NLS(‐) condition, albeit with a slight accumulation of GFP lacking the NLS‐peptide at the same location as dense DNA observed in several confocal micrographs of GUVs in NLS(‐) samples (Figure S3, Supporting Information). These confocal micrographs indicate successful assembly of nucleus‐like structures in GUVs.
Figure 3.

Formation of nucleus‐like structures in GUVs and immunostaining of nuclear pore complexes. A) GUVs after incubation for nuclear assembly reactions. RhPE: Lipid membrane, SYTO 41: nucleic acids (mainly DNA) stain. NLS(+): GFP with attached nuclear localization signals (NLS); NLS(‐): GFP without NLS peptide. See Figures S2,S3 (Supporting Information) for additional examples. B) A GUV containing a nucleus‐like structure fixed with 2% glutaraldehyde and immunostained with mAb414‐AF594 (top), and a nucleus formed under bulk condition, fixed and immunostained similarly (bottom). Arrowheads indicate GUV membrane (green) and nucleus‐like structure (magenta). See Figures S4,S5 (Supporting Information) for additional examples. Scale bar: 10 µm.
2.3. Immunostaining of Nuclear Pore Complexes on Nuclear Membrane
To verify the presence of a nuclear membrane on the surface of nucleus‐like structures formed in GUVs (top row of Figure 3A; Figure S2, Supporting Information), we conducted immunostaining of nuclear pore complexes (NPCs) using NPC antibodies (mAb414).[ 27 , 28 ] GUVs containing a nucleus‐like structure were fixed with 2.0% glutaraldehyde and stained with mAb414‐Alexa Fluor 594 (mAb414‐AF594), as detailed in “4. Experimental Section.” Confocal micrographs of the GUVs are shown in the top row of Figure 3B and Figure S4 (Supporting Information). As a positive control experiment, immunostaining was similarly conducted on nuclei assembled in bulk Xenopus interphase egg extract supplemented with sperm chromatin, as depicted in the bottom row of Figure 3B and Figure S5 (Supporting Information). Confocal images confirmed clear accumulation of mAb414‐AF594 signals at the periphery of nucleus‐like structures within GUVs, similarly to the positive control nuclei formed in bulk extract. Manual inspection of the micrographs revealed that more than 15% of nucleus‐like structures showed distinct NPC signals on their surfaces (28 nucleus‐like structures among the 169 structures fixed, immunostained, and inspected in total). The rest of nucleus‐like structures exhibited overstaining of their interior by mAb414‐AF594 (Figure S6, Supporting Information). These immunostaining results indicate the presence of nuclear membranes on the subset of nucleus‐like structures, thus validating the successful nuclear reconstitution in the GUVs.
2.4. Quantitative Characterization of Nucleus‐Like Structures in GUVs
To characterize nucleus‐like structures containing DNA and GFP‐NLS accumulated through nuclear import (top row of Figure 3A; Figure S2, Supporting Information), we analyzed fluorescence in GUVs formed under each of NLS(+) and NLS(‐) conditions and incubated for nuclear assembly reactions. We first defined two distinct compartments (C1 and C2) in GUVs containing a nucleus‐like structure carrying dense DNA (Figure 4A) and measured their mean fluorescence intensities (Figure S8, Supporting Information). We then computed the ratio of the fluorescence intensity (Figure 4B,C). The violin plot (Figure 4B) for the SYTO 41 intensity ratio showed similar distributions with mean values of ≈2.3 under both NLS conditions (t‐test results in Table S13, Supporting Information). In contrast, GFP intensity ratios differed significantly (p < 0.001, Table S14, Supporting Information) between conditions, with mean values of 1.6 for NLS(+) and 1.2 for NLS(‐) (Figure 4C). These results confirm (i) dense DNA localization in the C1 compartment, and (ii) significantly higher accumulation of GFP‐NLS in the nucleus‐like structures under the NLS(+) condition.
Figure 4.

Quantitative analysis of nucleus‐like compartments (NLCs) and nuclei formed in GUVs. A) Definition of internal compartments in a GUV. B) Ratio of SYTO 41 intensity between C1 and C2 compartments in GUVs. N = 182 for NLS(+), N = 193 for NLS(‐). C) Ratio of GFP intensity between C1 and C2 compartments. The threshold of GFP‐accumulation is mean + 3SD of NLS(‐), indicated with a black dashed line (threshold value: 1.5). D) Number of NLC‐containing GUVs in the observed GUVs plotted against τ (left) and Δ (right). E) Diameter of GUVs at τ = 120 min and Δ = 10%. GUVs containing an NLC are denoted as “w/ NLC”, GUVs without NLC as “w/o NLC”, and GUVs containing a nucleus as “w/ nucleus”. N = 163 for w/ NLC and w/o NLC, N = 28 for w/ nucleus. F) Volumes of GUVs containing an NLC and that of NLCs are plotted with grey circles. Volumes of GUVs containing a nucleus are plotted in magenta triangles. The green dashed line is a result of power fit (y = 0.086 x 1.18). N = 229 for NLCs, N = 28 for nuclei. G) Ratio of the volume of NLCs and nuclei to the volume of the GUVs. In panels B‐E and G, magenta bars indicate the Q1‐Q3 quartiles, while a green bar indicates the mean. See “4. Experimental Section” for the details on statistical analysis and Tables S13–S20 (Supporting Information) for the results.
To evaluate the impact of waiting time and chloroform addition on the formation of nucleus‐like structures in GUVs, we quantified structures containing both dense DNA and accumulated GFP‐NLS. We defined “nucleus‐like compartments” (NLCs) as C1 compartments having significantly higher GFP intensity than C2 compartments, using a threshold GFP intensity ratio of ≈1.5 (Figure 4C; see “4. Experimental Section” for details). We observed successful formation of NLC‐containing GUVs only under conditions where both waiting time and chloroform volume were non‐zero (Figure 4D). Among these parameters, we confirmed that only chloroform volume had a significant effect on the number of NLC‐containing GUVs, with no significant interaction between the two parameters (Tables S15–S17, Supporting Information; Figure 4D). These results indicate that chloroform addition promotes the formation of NLCs in GUVs.
To assess the impact of the GUV size on the successful formation of NLCs and nuclei confirmed by immunostaining, we calculated diameters of GUVs formed under the condition of τ = 120 min and Δ = 10%. Statistically significant differences (Tables S18,S19, Supporting Information) were observed among GUVs containing NLCs (mean diameter 6.6 µm), GUVs without NLCs (5.1 µm), and GUVs containing immunostaining‐confirmed nuclei (10.2 µm), as summarized in Figure 4E. Furthermore, plotting GUV diameters against NLC and nucleus diameters (Figure 4F) revealed a strong positive correlation (ρ ≈ 0.93; power‐law fit: y = 0.086 x 1.18). The corresponding NLC‐to‐GUV volume ratio and nucleus‐to‐GUV volume ratio were ≈0.27 and 0.25, respectively (Figure 4G, statistical details in Table S20, Supporting Information). These results suggest three points: (i) NLCs and nucleis are more likely to be formed in larger GUVs within the observed diameter range, (ii) the sizes of NLCs and nuclei positively correlate with the size of GUVs within the observed volume range, and (iii) the relative volumes of NLC and nucleus to the host GUV are similar across conditions.
3. Discussion
In this study, we achieved the reconstitution of the cell nucleus in GUVs formed by the inverted emulsion method. We observed that adding chloroform to the lipid‐dispersed oil improved multiple aspects of GUV formation: it increased the total number of GUVs (Figure 2B), enhanced egg extract encapsulation efficiency (Figure 2C), and led to the formation of more GUVs larger than 5 µm (Figure 2E). Additionally, allowing more time for lipid adsorption at the oil–egg extract interface further increased the fraction of larger GUVs relative to the total population (Figure 2F). We found the formation of numerous nucleus‐like structures in the GUVs demonstrating their nuclear import capability (Figure 3A; Figure S2, Supporting Information). Moreover, we confirmed the presence of nuclear pores on their surfaces (Figure 3B; Figure S4, Supporting Information), hence the presence of a nuclear membrane, by investigating through immunostaining of nuclear pore complexes. Furthermore, we identified an increase in the assembly frequency of nucleus‐like compartments (NLCs), particularly along with an increase of added chloroform volume, as seen in Figure 4D, and discovered a positive correlation between the size of GUVs and the size of internal NLCs and nuclei (Figure 4F).
In our investigation, we noted that the addition of chloroform not only increased the number of GUVs encapsulating the egg extract (Figure 2B,C) but also enabled the formation of GUVs encapsulating a high concentration of the egg extract (Figure S8, Supporting Information). We hypothesize that added chloroform in lipid‐dispersed oil enhance the adsorption of lipid molecules at the oil‐water interface and facilitate the formation of GUVs with more stable lipid membranes by the inverted emulsion method.[ 25 , 26 ] As a result, leakage of the encapsulated egg extract from the interior of the GUVs could have been reduced owing to the increased stability of the GUV membrane, while the internal solution of GUVs formed by the inverted emulsion method normally experiences dilution of the internal content,[ 29 , 30 ] as demonstrated in Figures S1,S8 (Supporting Information). Provided that the probability of the nuclear assembly event decreases through the loss of required molecules by the extract leakage, the higher concentration of the egg extract in GUVs could have contributed to the observed increase in NLC formation (Figure 4D).
In general, the inverted emulsion method[ 25 ] and its variants[ 29 , 31 ] are widely used techniques for GUV formation, alongside dewetting‐based microfluidic methods.[ 32 , 33 ] These approaches are commonly employed to encapsulate various molecular components (e.g., nucleic acids, cell‐free gene expression systems, cell extracts, and smaller synthetic compartments) within GUVs. In most implementations of the inverted emulsion method, chloroform is deliberately eliminated from lipid‐dispersed oil through evaporation as it is widely considered harmful to biochemical reactions embedded in GUVs.[ 34 , 35 ] On the other hand, recent investigations employing the inverted emulsion method have demonstrated successful induction of gene expression reactions[ 29 ] and the bundle formation of cytoskeletal proteins[ 36 , 37 , 38 , 39 ] in GUVs under conditions where chloroform was deliberately added into the lipid‐dispersed oil. These studies suggest that chloroform may have limited impact on biochemical reactions in GUVs, at least at the concentrations utilized in these studies. Therefore, we adopted chloroform concentrations in our lipid‐dissolved oil (Δ = 5/10%) consistent with those used in previous studies, leading to the formation of the numerous egg extract‐encapsulating GUVs (Figure 2) and successful nuclear and NLC assembly in the GUVs (Figures 3, 4; Figures S2,S4, Supporting Information).
The reconstitution of cell nuclei under micrometer‐scale 3D confinement has previously relied on water‐in‐oil emulsions, where the confirmation of assembled nuclei was achieved only through a nuclear import assay[ 20 , 21 , 22 ] as shown in Figure S9 (Supporting Information). In contrast, our approach involves encapsulating the egg extract in a lipid bilayer of GUVs and reconstitutes a nucleus in the GUVs. The semi‐permeability of the lipid bilayer allowed the exchange of molecules between the inside and outside of the GUVs, while essentially isolating the internal solution from the outer environment in confinement. This setup enabled the characterization of nucleus‐like structures in an additional approach, similarly to previous studies of in vitro nuclei formed in the bulk extract. We first identified the formation of nucleus‐like structures in GUVs by a nuclear import assay (Figure 3A) and additionally conducted their molecular characterization through immunostaining (Figure 3B). Our findings, indicating that only ≈17% of NLCs carried nuclear pore complexes on their surfaces, highlight the significance of GUV encapsulation in providing a more comprehensive understanding of in vitro nuclei formed under confinement in GUVs.
We obtained several insights into size. First, we observed a significantly higher mean diameter of ≈10.2 µm for GUVs containing a nucleus, as shown in Figure 4E, compared to the mean diameter of GUVs with or without NLC. We consider that this discrepancy may be attributed to an unidentified effect of the immunostaining procedure developed in this study but not necessarily a prerequisite for nuclear assembly to occur. Furthermore, we confirmed a proportional relationship between the volume of GUVs and that of NLCs and nuclei (Figure 4F), where the evaluated power‐law exponent fitted to 1.18. This exponent is larger than the known exponents (0.7‐0.9) between cell volume and nucleus volume in various natural cells,[ 40 ] resulting in a relatively higher nuclear‐to‐cytoplasmic (N/C) volume ratio in these GUVs compared to many natural cells (Figure 4G). We attribute this high N/C ratio to the large volumes of sperm chromatin encapsulated in the GUVs. Additionally, we discovered that the size range of GUVs containing an NLC and nucleus spanned ≈1 to 16 µm, consistent with reported dimensions of GUVs encapsulating Xenopus egg extract of unspecified types.[ 24 ] In contrast, we confirmed the presence of larger emulsions in the lipid‐dispersed oil just before the phase transfer procedure in the inverted emulsion method (Figure S10, Supporting Information). These observations might be linked to instances of GUV rupture arising from the inverted emulsion method.[ 33 , 41 , 42 ] Lastly, we found that a significant subset of the formed GUVs exhibited sizes smaller than the standard dimensions of Xenopus laevis sperm chromatin (≈10 µm along the long axis), suggesting the potential encapsulation of partial sperm chromatin fragments within the GUVs smaller than 10 µm. This small size could also explain the observed absence of GUVs carrying more than two nuclei. Considering the broader applicability of the proposed protocol, it is anticipated that the protocol could facilitate the complete encapsulation of arbitrarily long DNA molecules, including those at a genome‐scale. To achieve such encapsulation, it might be necessary to investigate methods for handling long DNA molecules to prevent fragmentation due to physical forces or to develop techniques for sorting GUVs to ensure the complete encapsulation of target DNA.
Taken together, this study has enabled the reconstitution of cell nuclei in GUVs, opening a range of potential applications. First, it may facilitate the investigation of the interaction between the cell cortex and nuclear assembly,[ 23 ] which has likely been hindered by the absence of cell cortex anchoring proteins at the boundary of water‐in‐oil emulsions.[ 43 ] Moreover, the established protocol holds promise for evolving into a method for transplanting artificial chromosomes into various eukaryotic cells, integrating with artificial chromosome/genome technologies[ 44 , 45 , 46 , 47 ] and GUV‐cell fusion techniques.[ 48 , 49 ] For chromosome transplantation, further optimization of lipid adsorption to the oil‐water interface and investigation into phase transfer conditions in the inverted emulsion method might be necessary to form large GUVs encapsulating DNA of arbitrary size. Finally, we believe that the reconstituted cell nuclei in GUVs will serve as a powerful tool for constructing artificial cellular systems closely mimicking eukaryotic cells in bottom‐up synthetic biology research.
4. Experimental Section
Preparation of Interphase Egg Extract and Sperm Chromatin of the Frog Xenopus Laevis
Xenopus egg extract has been extensively used in biological research to investigate various topics such as mitotic spindle assembly,[ 50 ] DNA replication,[ 51 ] chromatin organization,[ 52 ] cell cycle regulation,[ 53 ] and cytoskeleton[ 54 ] in vitro. In this study, we utilized its self‐organizing properties to construct cell nuclei within GUVs. While this approach provides insights into the fundamental principles of nuclear formation, it also serves as a link between biology and bottom‐up cell engineering. The ability of egg extract to drive nuclear assembly in a compartmentalized environment highlights its relevance beyond traditional biology, extending to artificial cell design and minimal cell models.
Interphase egg extract was prepared as described previously[ 55 ] with modifications as follows: to convert the cell cycle stage of the egg extract from mitosis into interphase, unfertilized eggs were crushed using KMH (100 mM KCl, 2.5 mM MgCl2, 20 mM HEPES‐KOH at pH 7.7) containing 1 mM CaCl2 rather than a calcium‐ionophore treatment; to completely separate the egg extract from insoluble material (e.g., actin filaments and mitochondria), crude egg extract isolated by the initial centrifugation was diluted in KMH (10% volume of the original extract), and then clarified by another round of centrifugation at 45 000 × g. Sperm chromatin was prepared as described previously.[ 55 ] In every preparation of the egg extract and sperm chromatin, their quality was evaluated by monitoring nuclear assembly in the bulk format (bottom row of Figure 3B; FigureS5, Supporting Information) and in water‐in‐oil emulsions (Figure S9, Supporting Information) under a fluorescence microscope.
Preparation of GFP‐NLS
GFP‐NLS in Figures 3B and 4B NLS(+), 4C,E w/ nucleus, 4F Nuclei, S1, S4–S6, S10 (Supporting Information) was prepared by following a standard protocol.[ 56 ] GFP‐NLS used in other sections of this paper was prepared by Dr. Yuki Hara by following a similar standard protocol. Briefly, Escherichia coli BL21(DE3) cells were transformed with a pGEX vector containing a GFP‐NLS gene. The cells were incubated in four 250 mL aliquots of LB medium at 30 °C with shaking at 250 RPM until OD600 ≈ 0.8. 1 mM IPTG was added, and the cultures were further incubated for 5 h. The cells were harvested by centrifugation, and the pellets were stored at ‐80 °C until next day. On the following day, the frozen cell pellets were resuspended in PBS lysis buffer (consisting of PBS pH 7.2 and 1% Triton X‐100) and lysed by gentle sonication. Then, the lysate was centrifuged at 12 000 × g, 4 °C for 15 min. The supernatant was collected and mixed with a 50:50 slurry of glutathione‐Sepharose beads in chilled PBS lysis buffer. The bead‐cell mix was incubated at 4 °C to trap proteins on the beads. Then, the beads were washed with ice‐cold PBS containing protease inhibitors and loaded into a disposable chromatography column. Trapped GST‐GFP‐NLS was eluted with ice‐cold 50 mM Tris‐HCl (pH 8.0) containing 20 mM reduced glutathione. The molecular weight of the collected GST‐GFP‐NLS was confirmed by polyacrylamide gel electrophoresis. Throughout this study, GST‐GFP‐NLS is referred to as “GFP‐NLS”.
Intra‐GUV Nuclear Assembly Protocol
To achieve reconstitution of cell nuclei in GUVs, we designed an experimental protocol as illustrated in Figure 1. Briefly, the protocol consists of three steps: 1) preparation of Xenopus interphase egg extract supplemented with sperm chromatin, 2) formation of GUVs encapsulating the sperm chromatin‐added interphase egg extract by the inverted emulsion method, and 3) induction of nuclear assembly reactions in the formed GUVs. In the first step, the sperm chromatin‐added egg extract was prepared for in vitro nuclear assembly reactions[ 15 , 16 , 17 ] as depicted in Figure 1A. In the second step, GUVs encapsulating the egg extract were formed at a chilled temperature by the inverted emulsion method[ 25 ] with two modifications to the conventional protocol: i) implementing prolonged waiting time and ii) adding chloroform into lipid‐dispersed oil to facilitate the formation of GUVs encapsulating the egg extract as illustrated in Figure 1B. In the third step, the GUVs were incubated at 22–23 °C to initiate the assembly of interphase nuclei within them as depicted in Figure 1C.
Formation of GUVs Encapsulating Xenopus Interphase Egg Extract
The lipid‐dispersed oil (lipid‐oil) was prepared using the following procedure. 1‐palmitoyl‐2‐oleoyl‐glycero‐3‐phosphocholine (POPC) at a concentration of 25 mg mL−1 in chloroform, and 1,2‐dioleoyl‐sn‐glycero‐3‐phosphoethanolamine‐N‐(lissamine rhodamine B sulfonyl) ammonium salt (RhPE) at 1 mg mL−1 in chloroform, both purchased from Avanti Polar Lipids (USA), were taken to a disposable glass bottle with a screw top (Laboran, As One, Japan). The chloroform was evaporated in a desiccator for 30–60 min using a vacuum pump. Mineral oil (M5904, Sigma Aldrich) was then immediately added to the bottle. The final composition of the lipid‐oil was 2.5 mM of POPC with 0.1% (mole percent) RhPE in mineral oil. For the GUVs in immunostaining experiment, RhPE was not added. Subsequently, chloroform (Δ = 0/5/10% depending on the experimental condition) was added using a disposable pipette. Here, we consider the potential effect of chloroform[ 57 ] on biological reactions within GUVs to be limited, as previous studies[ 29 , 36 , 37 ] have reported that proteins involved in these reactions retain their functionality. The screw top was tightly closed, and a strip of adhesive tape was attached to ensure sealing. The lipid‐oil was sonicated at 60 °C for 1 h and stored at room temperature until use. In all experiments, the lipid‐oil was consumed within a week after preparation. The lipid‐oil was sonicated at 60 °C for 1 h before each use.
GUVs were formed by the inverted emulsion method[ 25 ] according to the following protocol. First, two 1.5 mL disposable tubes and a 2.0 mL disposable centrifuge tube were prepared. 150 µL of egg lysis buffer (250 mM sucrose, 10 mM HEPES‐KOH pH 7.7, 50 mM KCl, 2.5 mM MgCl2, and 1 mM dithiothreitol)[ 58 ] was added to each of the 1.5 mL tubes, and 1.0 mL of lipid‐oil was added to the 2.0 mL centrifuge tube. All tubes were then placed on ice. Next, 25 µL of frozen Xenopus interphase egg extract stored at ‐80 °C was thawed on ice. Subsequently, 0.5 µL of energy mix (50 mM ATP, 50 mM MgCl2, 10 mM phosphocreatine, 100 µg mL−1 creatine kinase, pH 7.5 adjusted with NaOH) and 0.5 µL of GFP‐NLS (3.4 mg mL−1 for experiments in Figures 2 and 3A top, 4D,E w/ and w/o NLC, 4F,G NLCs, S2, S8,S9, S11,S12 (Supporting Information) and 11.1 mg mL−1 for experiments in Figures 3B and 4B NLS(+), 4C,E w/ nucleus, 4F Nuclei, 4G Nuclei, S1, S4–S6, S7 NLS(+), S10, (Supporting Information)) for NLS(+) condition or GFP (7.7 mg mL−1 for experiments in Figures 3A bottom, 4B,C NLS(‐), S3, S7 (Supporting Information) NLS(‐); purchased from Chromotek, Germany) for NLS(‐) condition were added to the thawed egg extract. This mixture was briefly vortexed and spun down. Subsequently, 0.5 µL of thawed Xenopus sperm chromatin was added on ice and the extract was mixed by gently pipetting four times. 25 µL of this extract mix was then added to 1 mL of chilled lipid‐oil in the 2.0 mL centrifuge tube. Additionally, 150 µL of lipid‐oil was layered on top of the egg lysis buffer in the two 1.5 mL tubes on ice. These three tubes were incubated on ice for the designated duration of waiting time (τ = 0/60/120 min).
Following the incubation of the oil‐water interface on ice, the mixture of lipid‐oil and the egg extract was vortexed for 1 min at 3200 RPM using a Vortex‐Genie 2 (Scientific Industries, Inc.). 500 µL of the vortexed mixture of the egg extract in lipid‐oil was immediately layered on top of each of the chilled lipid‐oil layers in the 1.5 mL tubes. The two 1.5 mL tubes were centrifuged at 9000 × g, 4 °C for 30 min. During this centrifugation, a new 1.5 mL tube filled with 1 mL of the egg lysis buffer was prepared and chilled on ice. Subsequently, the centrifuged tubes were collected, and the formed GUVs in the bottom pellet were transferred into 1 mL of the chilled egg lysis buffer in a 1.5 mL tube by piercing the side wall of the pellet in the tube with a syringe needle and applying air pressure from the open top of the tube using an index finger. Finally, the collected GUVs dispersed in the egg lysis buffer were vortexed briefly and kept on ice until further experiments.
Induction of Nuclear Assembly Reactions
Nuclear assembly in GUVs encapsulating sperm chromatin‐added Xenopus interphase egg extract was conducted by incubating the formed GUVs dispersed in the egg lysis buffer either on a tube rack at 23 °C or on a block incubator set at 22 °C for 90 min. Note that all GUVs encapsulating the egg extract formed by our inverted emulsion method were incubated for nuclear assembly reactions before fluorescence staining and microscopy.
Nuclear assembly under bulk condition was performed by the following procedure. First, the frozen egg extract, energy mix, GFP‐NLS, and sperm chromatin were thawed on ice. Subsequently, 1 µL of energy mix and 1 µL of GFP‐NLS were added to 50 µL of the thawed egg extract in a 0.5 mL tube. This egg extract was vortexed briefly, spun down, and placed on ice immediately. Then, 1 µL of sperm chromatin was added to the egg extract. This egg extract was gently pipetted four times, spun down briefly, and placed back on ice immediately. The 0.5 mL tube containing the extract mix was then placed on a block incubator set at 22 °C and incubated for 90 min to induce nuclear assembly reactions in the bulk egg extract.
Fluorescence Staining and Preparation of Glass Slide Samples for Microscopy
GUVs encapsulating the egg extract dispersed in the egg lysis buffer were centrifuged at 200 × g for 5 min at room temperature. The supernatant was carefully removed, and the sample volume was reduced to 140 µL. For fluorescence staining of DNA, 0.14 µL of 5 mM SYTO 41 (Thermo Fisher Scientific) was added to the sample by a 1000 × dilution. Subsequently, the stained GUVs were briefly vortexed and transferred into the open well of a Frame‐Seal chamber (SLF1201, Bio‐Rad) attached to a BSA‐coated glass slide. The chamber was immediately sealed with a No.1 glass coverslip coated with BSA. To facilitate microscopy, the glass slide sample was immediately inverted so that the No.1 coverslip faced downward, allowing the GUVs to settle toward the bottom surface prior to microscopy.
Microscopy
An inverted microscope (IX71, Olympus) equipped with an oil immersion objective (PlanApoN 60 ×, 1.45 NA, Olympus), fluorescence filters (460/80 nm, 520/35 nm, and 617/73 nm Bright‐Line single‐bandpass filters, Semrock, USA), a laser combiner (405/488/561 nm, ALC5000, Andor Technology, UK), a spinning disk confocal unit (CSU‐X1, Yokogawa, Japan), and an EM‐CCD camera (iXon X3, Andor Technology, UK) was used for all micrographs in the main text of this paper. Imaging sequences were programmed and executed using iQ2 software (Andor Technology, UK).
Immunostaining of Nuclear Pore Complexes on Nuclear Membranes
Immunostaining of nuclear pore complexes (NPCs) on the nuclei formed in the bulk form of the egg extract and in GUVs encapsulating the egg extract was conducted as follows.
For fixing nuclei formed in bulk form of the egg extract, 50 µL of the nuclei‐containing egg extract was first mixed with 150 µL of the egg lysis buffer and pipetted gently. 200 µL of fixation solution (4% glutaraldehyde in 80 mM KCl and 10 mM Tris‐HCl pH 7.7) was added, and the tube was immediately placed on ice and incubated for 1 h. After the incubation, the fixed nuclei were transferred to a 1.5 mL tube filled with 1 mL of quenching solution (10 mM Tris‐HCl pH 7.7, 250 mM sucrose, 50 mM KCl, 1% BSA) on ice. The sample was centrifuged at 200 × g, 4 °C for 5 min, and the supernatant was gently removed. The sample was then centrifuged again, and the supernatant was removed down to 100 µL. To stain NPCs on the membrane of the fixed nuclei, 1 µL of 0.5 mg mL−1 mAb414‐AF594 was added and gently mixed by pipetting. The fixed nuclei with mAb414‐AF594 were incubated on ice overnight. On the next day, the sample was centrifuged at 200 × g, 4 °C for 5 min. The supernatant was removed down to 100 µL, and 0.1 µL of 5 mM SYTO 41 was added for DNA staining. The entire volume of the immunostained nuclei was enclosed in a Frame‐Seal chamber between a No.1 glass coverslip and a glass slide, both of which were coated with BSA.
The fixation of nuclei formed in GUVs encapsulating the egg extract was performed in the following procedure. The GUVs were centrifuged at 200 × g, 4 °C for 5 min, and the supernatant was removed down to 100 µL. The tube containing the GUVs was placed on ice, and 100 µL of the fixation solution was added. After 1 h of incubation on ice, the fixed GUVs were mixed with 1 mL of quenching solution and centrifuged at 1000 × g for 5 min at 4 °C. The supernatant was removed, and the volume was reduced to 100 µL. The quenching and washing of the fixed GUVs were repeated once, and the sample volume was adjusted to 100 µL. The fixed GUVs with NPC‐antibodies were then incubated on ice overnight. The following day, 1 mL of quenching solution was added, the sample was centrifuged at 1000 × g, 4 °C for 5 min, and the supernatant was reduced down to 100 µL. 0.1 µL of 5 mM SYTO 41 was added for DNA staining, and the immunostained GUVs were enclosed in a Frame‐Seal chamber between a No.1 glass coverslip and a glass slide, both of which were coated with BSA.
Image Segmentation of GUVs
Image segmentation of GUVs on acquired micrographs was performed using cellpose 2.0 [ 59 , 60 ] implemented in Python. The envelopes of GUVs were primarily segmented using a built‐in model (“CP”), and the quality of the segments was manually inspected and corrected on the graphical user interface (GUI) of cellpose 2.0.
Number, Internal GFP Intensity, and Diameter of GUVs
The analysis of GUV fluorescence using above generated segment masks was performed in MATLAB. The number of GUVs was determined by computing the number of segments. The mean GFP intensity in the GUVs, denoted as I GFP, was computed by extracting intensity values in the GFP channel using the segmentation mask and taking their mean. The diameter of the GUVs was defined as the reduced diameter of each circle having a corresponding area of individual segments. To determine the mean GFP intensity in the background of each micrograph, three arbitrary rectangular regions with at least 1056 pixels were carefully selected in the background of each micrograph. The corresponding mean GFP fluorescence intensity was computed for each rectangular region, and the average of the three means was calculated. The threshold of GFP encapsulation (dashed lines in Figure S8, Supporting Information) was defined by mean + 3SD of the mean GFP intensity in each background.
Exclusion of GUVs Containing Aggregated GFP
GUVs containing aggregated GFP were manually excluded from the dataset used to compute the proportion of GUVs encapsulating the GFP‐dispersed egg extract in the observed GUVs (Figure 2C). This exclusion aimed to mitigate artifacts in the computed proportion arising from GFP aggregation in 3D space. This issue was observed in all micrographs acquired after completing the entire protocol of nuclear assembly in GUVs (Figure 1). Since the GUVs in the micrographs of Figure 2 had already undergone 23 °C incubation for nuclear assembly reactions, several GUVs in the acquired micrographs exhibited positive indications of nuclear import by GFP‐NLS within them. Theoretically, the mean GFP intensity computed from a confocal micrograph of such GUVs with aggregated GFP always yielded a higher mean GFP intensity than a confocal micrograph of GUVs without GFP aggregation even if the same amount of GFP was encapsulated. Consequently, the mean GFP intensity of the GUVs containing the aggregation did not precisely reflect the concentration of GFP encapsulated in the GUV. Because the purpose of the analysis in Figure 2C was to evaluate GFP encapsulation in the GUVs, we considered the inclusion of data from GUVs carrying such aggregated GFP inadequate and excluded the GUVs from this specific analysis in Figure 2C. The same parameter computed from data including the GUVs containing aggregated GFP is shown in Figure S11 (Supporting Information). Additionally, raw GFP intensity values in the GUV lumen and the background of these GUVs are plotted in Figure S12 (Supporting Information). Comparisons between plots excluding the GUVs containing aggregated GFP (Figure 2C; Figure S8, Supporting Information) and those including them (Figures S11‐S12, Supporting Information) indicate only minor changes.
Definition and Identification of NLCs in GUVs
To differentiate between C1 compartments (Figure 4A) containing a significantly high level of GFP‐NLS from those with a lower level, we set a threshold for the GFP intensity ratio, as indicated by the dashed line in Figure 4C. This threshold was determined as the mean + 3SD of the GFP intensity ratio under NLS(‐) conditions (dashed line in Figure 4C). We used this threshold to interpret accumulation of GFP‐NLS in C1 compartment: if the ratio exceeded the threshold, it indicated GFP‐NLS accumulation. Utilizing this threshold, we defined a “nucleus‐like compartment” (NLC) as a C1 compartment with a GFP intensity ratio higher than the threshold.
To identify NLCs in GUVs, GUVs containing dense DNA (C1 compartment in Figure 4A) were initially identified in micrographs through manual inspection. Subsequently, the envelopes of the GUVs and their internal C1 compartments were manually segmented in RhPE and SYTO41 channels using the interactive drawfreehand function in MATLAB. Mean intensity values of SYTO 41 signals in the C1 and C2 compartments were then computed using the segment masks. Similarly, mean GFP intensities in the C1 and C2 compartments were computed using the same segment masks. Next, the ratio of mean intensities in the C1 and C2 compartments was computed for both the SYTO 41 and GFP channels. The threshold for the GFP intensity ratio was determined based on the above definition (computed threshold: ≈1.5). Furthermore, to ensure the encapsulation of DNA and GFP‐NLS in the NLCs, the mean fluorescence intensity of both SYTO 41 and GFP in the background (Figure S7, Supporting Information) was calculated. This computation was done by extracting three arbitrary rectangular regions from the background, each containing at least 1517 pixels. The mean fluorescence intensity of each region was computed, and the average of these three mean values was taken.
Number and Size of GUVs Containing an NLC
The number of GUVs containing an NLC was determined by manually inspecting all confocal micrographs of GUVs encapsulating the egg extract after 90 min of incubation at 22 °C. GUVs carrying dense DNA (C1 compartment) were manually identified, and each C1 compartment was evaluated to determine whether it contained an NLC, following the established definition. The diameters of GUVs containing an NLC and those not containing an NLC at τ = 120 min and Δ = 10%, as shown in Figure 4E, were computed using the following procedure. Accurate manual image segmentation of GUVs containing an NLC was conducted when all NLCs were identified. The same number of segments from GUVs without an NLC were randomly selected from the micrographs. Using the segments of these GUVs, the reduced diameter was computed from their segment area. The volumes of GUVs containing an NLC and nucleus, as well as the volumes of the corresponding NLC and nucleus, were computed from the segment area by calculating the reduced radius and then the corresponding reduced volume as a sphere.
Statistical Analysis
In the statistical analyses depicted in Figure 2B,C,E,F, 4D, and S11 (Supporting Information), we conducted a two‐way ANOVA followed by post‐hoc Tukey's HSD tests, focusing either on the duration of waiting time or the added volume of chloroform. For the statistical analyses in Figure 4B,C, we performed a two‐sample t‐test. For the statistical analysis in Figure 4E, we used the Kruskal‐Wallis test followed by a post‐hoc Mann‐Whitney U test with Bonferroni's correction. In the statistical analysis shown in Figure 4G, we employed the Wilcoxon rank‐sum test. For all analyses, resultant p‐values were rounded to the first significant digit and annotated using the conventional method: “n.s.” (not significant) for p > 0.05, “*” for p ≤ 0.05, “**” for p ≤ 0.01, and “***” for p ≤ 0.001. The results of all statistical analyses are summarized in Tables S1–S23 (Supporting Information).
Conflict of Interest
The authors declare no conflict of interest.
Author Contributions
Conceptualization: S.T.1(S.Takeuchi), M.O., and S.T.2(S.Takamori); Methodology: S.T.1, M.O., K.S., T.O., S.T.2, H.M., T.K., and M.S.; Investigation: K.S., S.T.2, and M.S.; Visualization: S.T.2; Supervision: S.T.1, M.O., K.S., T.O., H.M., T.K., and M.S.; Writing—original draft: S.T.2; Writing—review & editing: S.T.1, M.O., K.S., T.O., S.T.2, H.M., T.K., and M.S.
Supporting information
Supporting Information
Acknowledgements
The authors thank Prof. Dr. Yuki Hara (Yamaguchi University, Japan) for kindly offering purified GFP‐NLS and the corresponding plasmid. This work was supported by JST CREST JPMJCR18S5 (S.Takeuchi and M.O.), JSPS KAKENHI JP22K15080 (S.Takamori), JSPS KAKENHI JP19H05755 (K.S.), JSPS KAKENHI JP22H02551 (K.S.), and JSPS KAKENHI JP23K27178 (M.O.).
Takamori S., Mimura H., Osaki T., Kondo T., Shintomi M., Shintomi K., Ohsugi M., Takeuchi S., Nuclear Assembly in Giant Unilamellar Vesicles Encapsulating Xenopus Egg Extract. Small 2025, 21, 2412126. 10.1002/smll.202412126
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
- 1. Jia H., Schwille P., Curr. Opin. Biotechnol. 2019, 60, 179. [DOI] [PubMed] [Google Scholar]
- 2. Simmel F. C., Emerging Topics in Life Sciences 2019, 3, 587. [DOI] [PubMed] [Google Scholar]
- 3. Buddingh’ B. C., van Hest J. C., Acc. Chem. Res. 2017, 50, 769. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Gaut N. J., Adamala K. P., Adv. Biol. 2021, 5, 2000188. [DOI] [PubMed] [Google Scholar]
- 5. Elani Y., Angew. Chem. 2021, 133, 5662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Lee K. Y., Park S. J., Lee K. A., Kim S. H., Kim H., Meroz Y., Mahadevan L., Jung K. H., Ahn T. K., Parker K. K., Shin K., Nat. Biotechnol. 2018, 36, 530. [DOI] [PubMed] [Google Scholar]
- 7. Berhanu S., Ueda T., Kuruma Y., Nat. Commun. 2019, 10, 1325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Kumar B. P., Fothergill J., Bretherton J., Tian L., Patil A. J., Davis S. A., Mann S., Chem. Commun. 2018, 54, 3594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Otrin L., Marušič N., Bednarz C., Vidakovic‐Koch T., Lieberwirth I., Landfester K., Sundmacher K., Nano Lett. 2017, 17, 6816. [DOI] [PubMed] [Google Scholar]
- 10. Marušič N., Otrin L., Zhao Z., Lira R. B., Kyrilis F. L., Hamdi F., Kastritis P. L., Vidaković‐Koch T., Ivanov I., Sundmacher K., Dimova R., Proc. Natl. Acad. Sci. USA 2020, 117, 15006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Westensee I. N., Brodszkij E., Qian X., Marcelino T. F., Lefkimmiatis K., Städler B., Small 2021, 17, 2007959. [DOI] [PubMed] [Google Scholar]
- 12. Deng N. N., Yelleswarapu M., Zheng L., Huck W. T., J. Am. Chem. Soc. 2017, 139, 587. [DOI] [PubMed] [Google Scholar]
- 13. Aufinger L., Simmel F. C., Angew. Chem., Int. Ed. 2018, 57, 17245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Göpfrich K., Platzman I., Spatz J. P., Trends Biotechnol. 2018, 36, 938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Lohka M. J., Masui Y., Science 1983, 220, 719. [DOI] [PubMed] [Google Scholar]
- 16. Newmeyer D. D., Lucocq J. M., Bürglin T. R., De Robertis E. M., EMBO J. 1986, 5, 501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Newport J., Cell 1987, 48, 205. [DOI] [PubMed] [Google Scholar]
- 18. Hara Y., Merten C. A., Dev. Cell 2015, 33, 562. [DOI] [PubMed] [Google Scholar]
- 19. Bisht J., LeValley P., Noren B., McBride R., Kharkar P., Kloxin A., Gatlin J., Oakey J., Lab Chip 2019, 19, 3499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Good M. C., The Mitotic Spindle: Methods and Protocols 2016, 87. [PubMed] [Google Scholar]
- 21. Guan Y., Li Z., Wang S., Barnes P. M., Liu X., Xu H., Jin M., Liu A. P., Yang Q., Elife 2018, 7, 33549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Guan Y., Wang S., Jin M., Xu H., Yang Q., JoVE (Journal of Visualized Experiments) 2018, 139, 58240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Bermudez J. G., Chen H., Einstein L. C., Good M. C., genesis 2017, 55, 23013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Chiba M., Miyazaki M., Ishiwata S. I., Biophys. J. 2014, 107, 346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Pautot S., Frisken B. J., Weitz D. A., Langmuir 2003, 19, 2870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Claudet C., In M., Massiera G., The European Physical Journal E 2016, 39, 1. [DOI] [PubMed] [Google Scholar]
- 27. Dilsaver M. R., Chen P., Thompson T. A., Reusser T., Mukherjee R. N., Oakey J., Levy D. L., Mol. Biol. Cell 2018, 29, 3155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Nord M. S., Bernis C., Carmona S., Garland D. C., Travesa A., Forbes D. J., Nucleus 2020, 11, 178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Van de Cauter L., Fanalista F., Van Buren L., De Franceschi N., Godino E., Bouw S., Danelon C., Dekker C., Koenderink G. H., Ganzinger K. A., ACS Synth. Biol. 2021, 10, 1690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Shimane Y., Kuruma Y., Frontiers in Bioengineering and Biotechnology 2022, 10, 873854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Abkarian M., Loiseau E., Massiera G., Soft Matter 2011, 7, 4610. [Google Scholar]
- 32. Deng N., Yelleswarapu M., Huck W. T. S., J. Am. Chem. Soc. 2016, 138, 7584. [DOI] [PubMed] [Google Scholar]
- 33. Deshpande S., Caspi Y., Meijering A. E. C., Dekker C., Nat. Commun. 2016, 7, 10447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Nishimura K., Matsuura T., Nishimura K., Sunami T., Suzuki H., Yomo T., Langmuir 2012, 28, 8426. [DOI] [PubMed] [Google Scholar]
- 35. Walczak M., Brady R. A., Mancini L., Contini C., Rubio‐Sánchez R., Kaufhold W. T., Cicuta P., Di Michele L., Nat. Commun. 2021, 12, 4743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Loiseau E., Schneider J. A., Keber F. C., Pelzl C., Massiera G., Salbreux G., Bausch A. R., Sci. Adv. 2016, 2, 1500465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Litschel T., Ramm B., Maas R., Heymann M., Schwille P., Angew. Chem., Int. Ed. 2018, 57, 16286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Litschel T., Kelley C. F., Holz D., Adeli Koudehi M., Vogel S. K., Burbaum L., Mizuno N., Vavylonis D., Schwille P., Nat. Commun. 2021, 12, 2254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Baldauf L., Frey F., Perez M. A., Idema T., Koenderink G. H., Biophys. J. 2023, 122, 2311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Hara Y., J. Cell Sci. 2020, 133, jcs241869. [DOI] [PubMed] [Google Scholar]
- 41. Yandrapalli N., Seemann T., Robinson T., Micromachines 2020, 11, 285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Moga A., Yandrapalli N., Dimova R., Robinson T., ChemBioChem 2019, 20, 2674. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Sakamoto R., Tanabe M., Hiraiwa T., Suzuki K., Ishiwata S. I., Maeda Y. T., Miyazaki M., Nat. Commun. 2020, 11, 3063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Murray A. W., Szostak J. W., Nature 1983, 305, 189. [DOI] [PubMed] [Google Scholar]
- 45. Harrington J. J., Bokkelen G. V., Mays R. W., Gustashaw K., Willard H. F., Nat. Genet. 1997, 15, 345. [DOI] [PubMed] [Google Scholar]
- 46. Gibson D. G., Benders G. A., Andrews‐Pfannkoch C., Denisova E. A., Baden‐Tillson H., Zaveri J., Stockwell T. B., Brownley A., Thomas D. W., Algire M. A., Merryman C., Young L., Noskov V. N., Glass J. I., Venter J. C., Hutchison C. A. III, Smith H. O., Science 2008, 319, 1215. [DOI] [PubMed] [Google Scholar]
- 47. Hutchison C. A. III, Chuang R. Y., Noskov V. N., Assad‐Garcia N., Deerinck T. J., Ellisman M. H., Pelletier J. F., Qi Z., Richter R. A., Strychalski E. A., Sun L., Suzuki Y., Tsvetanova B., Wise K. S., Smith H. O., Glass J. I., Merryman C., Gibson D. G., Venter J. C., Science 2016, 351, aad6253. [DOI] [PubMed] [Google Scholar]
- 48. Saito A. C., Ogura T., Fujiwara K., Murata S., Nomura S. I. M., PLoS One 2014, 9, 106853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Takamori S., Cicuta P., Takeuchi S., Di Michele L., Nanoscale 2022, 14, 14255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Desai A., Murray A., Mitchison T. J., Walczak C. E., Methods in Cell Biology 1998, 61, 385. [DOI] [PubMed] [Google Scholar]
- 51. Walter J., Sun L., Newport J., Mol. Cell 1998, 1, 519. [DOI] [PubMed] [Google Scholar]
- 52. Philpott A., Leno G. H., Cell 1992, 69, 759. [DOI] [PubMed] [Google Scholar]
- 53. Murray A. W., Methods in cell biology 1991, 36, 581. [PubMed] [Google Scholar]
- 54. Gard D. L., Kirschner M. W., J. Cell Biol. 1987, 105, 2191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Shintomi K., Hirano T., Methods in Molecular Biology 2017, 1515, 3. [DOI] [PubMed] [Google Scholar]
- 56. Einarson M. B., Pugacheva E. N., Orlinick J. R., Cold Spring Harbor Protocols 2007, pdb‐prot4738. [DOI] [PubMed]
- 57. Xiong E., Wu X., Yang L., Gong F., Tai F., Wang W., PLoS One 2014, 9, 112724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Cheng X., Ferrell Jr J. E., Science 2019, 366, 631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Stringer C., Wang T., Michaelos M., Pachitariu M., Nat. Methods 2021, 18, 100. [DOI] [PubMed] [Google Scholar]
- 60. Pachitariu M., Stringer C., Nat. Methods 2022, 19, 1634. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supporting Information
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
